Latest National Cancer Institute Stories
By the National Cancer Institute BETHESDA, Md., Sept. 24, 2014 /PRNewswire-USNewswire/ -- An African American man in his 60's has read about a new targeted therapy for lung cancer.
Contract Funds 3D Breast Cancer, 3D Brain Cancer Micro-Tumor Development GREENVILLE, S.C., Sept.
A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important
A new public-private partnership is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S.
The anti-cancer drug Xalkori® is being investigated by the ECOG-ACRIN Cancer Research Group in E4512, a phase III trial. Philadelphia, PA (PRWEB) August
TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp.
By the National Cancer Institute BETHESDA, Md., Aug.
- To give a box on the ear to.